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Objectives: The purpose of this study was to investigate the molecular epidemiology of CTX-M-14-producing
Escherichia coli clinical isolates from Korea.
Methods: A total of 138 non-duplicate E. coli clinical isolates showing reduced susceptibility or resistance to
ceftazidime and/or cefotaxime were included in the study. Resistance genes, genetic environment, R plasmid
size and replicon type, sequence type (ST) and XbaI-macrorestriction patterns were determined.
Results: Among 138 isolates, 35 were found to carry the blaCTX-M-14 gene. The ISEcp1 element was identified in
the upstream region of the blaCTX-M-14 gene in 32 isolates. The blaCTX-M-14 gene was located on an IncF plasmid
in 21 isolates, on an IncA/C plasmid in 1 isolate, on the chromosome in 8 isolates and on both the chromosome
and an IncF plasmid in 5 isolates. The most prevalent ST was ST405 (n¼8), followed by ST354 (n¼4), ST38
(n¼3), ST69 (n¼3) and the intercontinental ST, ST131 (n¼3). PFGE and multilocus sequence typing exper-
iments demonstrated no major clonal relationship among the CTX-M-14-producing isolates.
Conclusions: The blaCTX-M-14 gene was probably mobilized by IncF plasmids, which can readily spread in E. coli,
causing horizontal dissemination of the resistance gene in Korea.
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Introduction
CTX-M-14 is one of the most successful plasmid-borne extended-
spectrum b-lactamases (ESBLs) in the Enterobacteriaceae,
especially in Escherichia coli, and shows worldwide distribution.1
The rapid dissemination of blaCTX-M genes involves plasmid or
strain epidemics, as well as mobile genetic elements such as
ISEcp1-like elements.1,2 Recent reports on the intercontinental
dissemination of E. coli clone of sequence type (ST) 131 harbour-
ing CTX-M-15 emphasize the importance of epidemiologic
studies on strains producing CTX-M enzymes.3,4
The blaCTX-M-14 gene is mainly associated with ISEcp1-like
elements,2 although two cases of the blaCTX-M-14 gene in associ-
ation with a complex class 1 integron containing ISCR1 on a
plasmid from clinical isolates of E. coli have been described in
Korea.5,6 The blaCTX-M-14 gene has been found in diverse E. coli
clones of ST10, ST23, ST131, ST155 and ST359 and on plasmids
of diverse incompatibility (Inc) groups, such as IncA/C, IncHI2,
IncF and IncK.7–9 The recent development of a replicon sequence
typing method enables us to compare IncF plasmids from
different bacterial isolates more precisely.10 Here we describe
the characteristics of IncF plasmids carrying the blaCTX-M-14
gene in E. coli isolates of diverse STs recovered at hospitals
in Korea.
Materials and methods
Bacterial strains
The 138 non-duplicate E. coli isolates in this study were isolated in 11
different hospitals in Korea between May and June 2005 and identified
using either a Vitek GNI card (bioMe´rieux, Marcy l’E´toile, France) or a
MicroScan GN combo card (Dade Behring, West Sacramento, CA, USA).
Antimicrobial susceptibility testing
Antimicrobial susceptibilities were tested by disc diffusion on Mueller–
Hinton (MH) agar (Difco, Cockeysville, MD, USA) and by the agar dilution
method according to the interpretative criteria proposed by the CLSI.11
MICs of b-lactams were determined alone or in combination with a
fixed concentration of clavulanic acid (4 mg/L). The double-disc synergy
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test for confirmation of ESBL activity was carried out as described pre-
viously.12 E. coli ATCC 25933 was used as an MIC reference strain.
b-Lactamase gene identification
Detection of genes coding for plasmid-borne ESBLs and AmpC
b-lactamases was performed by PCR amplification with primers as
described previously.12,13 The PCR products were subjected to direct
sequencing with an automated DNA sequencer (model 3730xl; Applied
Biosystems, Weiterstadt, Germany).
Analysis of genetic elements surrounding
the blaCTX-M-14 gene
Genetic organization of the blaCTX-M-14 gene was investigated by PCR and
sequencing of regions surrounding the gene.14 The internal ISEcp1
forward and blaCTX-M-14 reverse primers were used to investigate
regions upstream of the blaCTX-M-14 gene, and forward primers of
blaCTX-M-14 and reverse primers of IS903, orf3, orf477, orf1005, d-iron
and mucA genes were used downstream of the blaCTX-M-14 gene.
Transfer of resistance
Conjugation experiments were carried out between the donors and the
azide-resistant recipient strain E. coli J53. Transconjugants were selected
on MH agar plates supplemented with cefotaxime (2 mg/L) and sodium
azide (100 mg/L).
PCR-based replicon typing of plasmids
Plasmid replicon typing of the isolates carrying the blaCTX-M-14 gene was
performed by a PCR-based method with 18 pairs of primers as described
by Carattoli et al.15
PFGE
Plugs containing whole genomic DNA from the E. coli isolates were
digested with XbaI, I-CeuI or S1 nuclease. DNA fragments were separated
by PFGE using a CHEF-DRII device (Bio-Rad, Hercules, CA, USA). The PFGE
conditions of XbaI-macrorestriction analysis were 6 V/cm for 20 h with
pulse times ranging from 0.5–60 s at a temperature of 148C. The pulse
times for S1 nuclease and I-CeuI restriction analysis were 9–90 s.
Lambda ladder (Bio-Rad) was used as a DNA size marker. Tiff format
gel images were exported to Molecular Analyst Fingerprinting Software
(version 3.2; Bio-Rad) for analysis. Comparisons for E. coli isolates were
made by using the band-based dice coefficient. Dendrograms were gen-
erated using the unweighted pair group with arithmetic averages method
with 1.0% position tolerance, and DNA relatedness was calculated based
on the criteria of Tenover et al.16
Southern blotting
Plasmids linearized with S1 nuclease or I-CeuI-digested chromosomal
DNA were blotted onto nylon membranes (Bio-Rad) and hybridized with
probes specific for the blaCTX-M-14, blaTEM-1 or 16S rRNA genes. Probe lab-
elling, hybridization and detection were performed with the DIG DNA
Labeling and Detection Kit (Roche Diagnostics, Indianapolis, IN, USA) fol-
lowing the manufacturer’s protocols.
Multilocus sequence typing (MLST)
MLST was performed on CTX-M-14-producing E. coli isolates using seven
conserved housekeeping genes (adk, fumC, gyrB, icd,mdh, purA and recA)
following protocols at http://mlst.ucc.ie/mlst/dbs/Ecoli.
Replicon sequence typing of IncF plasmids
Replicon sequence typing was performed on IncF plasmids carrying the
blaCTX-M-14 gene in E. coli isolates for the genes encoding replicons FII,
FIA and FIB following protocols at http://pubmlst.org/plasmid/.
Nucleotide sequence accession numbers
Nucleotide sequence data reported in this paper are available in the
GenBank nucleotide database under accession number EU136399
(E. coli SCE0510).
Results and discussion
Description of clinical isolates and ESBL genotype
Among 138 ESBL-producing E. coli isolates, 35 (25.4%) carried
the blaCTX-M-14 gene (Table 1). Other types of ESBL genes, includ-
ing blaCTX-M-3 (n¼7), blaCTX-M-9 (n¼8), blaCTX-M-12 (n¼1),
blaCTX-M-15 (n¼58), blaCTX-M-57 (n¼1), blaSHV-2a (n¼8), blaSHV-12
(n¼17) and blaTEM-52 (n¼4), were also detected. ESBL genes
were not detected in eight isolates with an ESBL phenotype.
Genes encoding AmpC b-lactamases were detected in 24 iso-
lates carrying the ESBL genes: the blaCMY-2 gene in 14 isolates,
the blaCMY-10 gene in 1 isolate and the blaDHA-1 gene in 9 isolates.
The blaTEM-1 gene was detected in 28/35 isolates carrying the
blaCTX-M-14 gene, some of which also harboured blaSHV-12 (n¼1)
and blaCMY-2 (n¼6) (Figure 1). One isolate (HYE0515) carried
b-lactamase genes blaTEM-1, blaSHV-2a and blaCTX-M-15, and
seven isolates carried blaCTX-M-14 only. MICs of b-lactams for
CTX-M-14-producing isolates are shown in Table 1.
Strain typing
PFGE of XbaI-digested DNA showed a genetic similarity,85% for
most of the 35 CTX-M-14-producing isolates, which were con-
sidered to be unrelated (Figure 1). Although the isolates from
different hospitals were heterogeneous, as seen on the dendro-
gram, some isolates recovered in the same hospital showed an
identical PFGE pattern, suggesting possible small clonal out-
breaks in these hospitals. MLST experiments identified 15
unique STs in 35 isolates and discovered a new ST, ST2026
(6-4-225-247-9-1-20). The most prevalent ST was ST405
(n¼8), followed by ST354 (n¼4), ST38 (n¼3), ST69 (n¼3) and
the intercontinental ST, ST131 (n¼3).
Genetic contexts of the blaCTX-M-14 gene
ISEcp1-like elements were identified in the upstream region of
the blaCTX-M-14 gene in 32/35 isolates. The 32 isolates were classi-
fied into four different types according to their genetic environ-
ment: type I (n¼20), type II (n¼10), type III (n¼1) and type
IV (n¼1) (Figure 2). Type I was characterized by ISEcp1-like
elements in the upstream region and IS903 in the downstream
region of the blaCTX-M-14 gene. Type II showed an identical struc-
ture to type I in the upstream region of the blaCTX-M-14 gene,
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however, the downstream IS903 element was absent. Type III
also showed a structure similar to type I, but IS10 disrupted
the 3′ non-coding region of an ISEcp1-like element upstream
of the blaCTX-M-14 gene (DISEcp1-IS10-blaCTX-M-14-IS903). Finally,
type IV also showed a structure similar to type I, but IS26 dis-
rupted a 5′ open reading frame region of the ISEcp1 upstream
of the blaCTX-M-14 gene (DIS26-DISEcp1-blaCTX-M-14-IS903). Type
I and type II possessed right-inverted repeats (IRRs;
5′-CACACGTGGAATTTAGG-3′, 17 bp) of ISEcp1 between the
ISEcp1 and blaCTX-M-14 gene, and a sequence of 42 bp common
to all type I and II isolates was observed between the IRRs
and the blaCTX-M-14 start codon. This 42 bp sequence was also
detected downstream of IS10 in type III and DISEcp1 in type
IV isolates. Left-inverted repeats (5′-TTTGTTGAATAAATC-3′,
15 bp) of the IS903 element were observed between the
blaCTX-M-14 gene and IS903 element in types I, III and IV.
Location of the blaCTX-M-14 gene
Conjugation experiments for the blaCTX-M-14 gene were successful
in only 18/35 isolates, despite repeated attempts. A probe
specific for the blaCTX-M-14 gene hybridized with IncF plasmids
of various sizes, ranging from 70–300 kb, in 26 isolates. The
probe hybridized with a 150 kb IncA/C plasmid in one isolate.
Table 1. Characteristics of E. coli isolates carrying the blaCTX-M-14 gene
Isolate Specimen DDS Transfer
MIC (mg/L)
ATM CAZ CAZ/CLA CTX CTX/CLA FEP FEP/CLA
AJE0507 urine + 2 32 4 1 64 4 64 4
AJE0509 urine + 2 8 1 0.5 64 4 16 1
AJE0510 urine + + 2 0.5 0.25 32 1 4 0.5
BDE0504 urine + + 8 1 0.5 32 2 16 1
BDE0516 fluid + 2 64 2 0.5 64 2 8 0.5
HYE0515 urine + + .256 .256 32 .256 128 256 16
JNE0502 urine 2 + 128 2 0.25 32 1 4 0.5
JNE0507 urine + + 8 4 0.5 256 1 8 8
JNE0510 urine + + 16 32 32 64 16 32 1
KSE0510 urine + + 8 1 0.25 32 2 16 1
KSE0512 blood + 2 16 1 0.5 64 1 32 0.5
KSE0519 wound + + 16 2 0.5 64 1 16 0.5
SCE0502 wound + 2 4 1 0.12 32 0.5 16 0.25
SCE0503 sputum + 2 16 4 0.5 32 2 32 0.5
SCE0506 sputum + + 8 8 0.5 32 1 16 0.5
SCE0507 sputum + + 8 8 0.5 32 2 16 1
SCE0508 wound + + 16 16 0.5 32 4 16 2
SCE0510 wound + + 64 64 0.5 64 4 16 2
SCE0513 urine + 2 128 16 4 256 32 64 1
SCE0514 urine + 2 8 8 0.25 32 0.5 16 0.5
SCE0516 urine + + 16 16 0.5 32 4 16 1
SME0507 urine + 2 32 32 32 64 32 32 4
SME0509 urine + 2 8 2 1 32 2 8 1
SME0511 urine + 2 8 2 1 32 2 8 0.5
SME0512 urine 2 2 32 16 16 16 16 8 0.5
SME0513 urine + + 8 0.5 0.25 32 2 4 0.5
SNE0506 urine + + 32 16 0.5 64 1 16 0.25
SSE0501 urine + 2 32 64 32 32 32 16 2
SSE0511 urine + 2 32 64 64 64 32 32 4
SSE0514 sputum + 2 4 1 0.5 16 0.25 4 0.25
SSE0519 urine + + 32 64 64 32 32 16 2
WKE0502 urine + 2 4 0.5 0.5 16 0.5 4 0.5
WKE0505 urine + 2 64 16 16 128 128 64 32
WKE0506 urine + + 32 8 4 128 32 32 16
WKE0507 wound + + 32 2 0.5 128 4 32 1
DDS, double-disc synergy [in the DDS test, cefotaxime (30 mg), ceftazidime (30 mg) and cefepime (30 mg) discs were placed adjacent to an amoxicillin/
clavulanic acid disc (20/10 mg) at inter-disc distances (centre to centre) of 20 mm on Mueller–Hinton agar]; ATM, aztreonam; CAZ, ceftazidime; CAZ/
CLA, ceftazidime/clavulanic acid; CTX, cefotaxime; CTX/CLA, cefotaxime/clavulanic acid; FEP, cefepime; FEP/CLA, cefepime/clavulanic acid.
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Figure 1. Dendrogram based on XbaI-macrorestriction patterns of E. coli isolates producing CTX-M-14. The broken line indicates 85% similarity. E. coli isolates showing similarities of
,85% were considered to be unrelated. The location of the blaCTX-M-14 gene is indicated in the far right-hand columns.
aXbaI-macrorestriction analysis yielded no DNA banding patterns
due to the degradation of the genomic DNA during preparation of the agarose plugs.
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The probe also hybridized with I-CeuI-macrorestriction frag-
ments ranging from 70–800 kb in 13 isolates. A probe specific
for 16S rDNA also hybridized to I-CeuI-macrorestriction frag-
ments of identical sizes, indicating the presence of a blaCTX-M-14
gene in the chromosome. In summary, the blaCTX-M-14 gene
was located on an IncF plasmid in 21 isolates, on an IncA/C
plasmid in 1 isolate, in the chromosome in 8 isolates and on
both an IncF plasmid and the chromosome in 5 isolates.
Notably, the blaTEM-1 gene was also present in the same IncF
plasmid in 20 isolates.
Replicon sequence types of IncF plasmids
A total of 16 replicon STs were identified in 26 IncF plasmids car-
rying the blaCTX-M-14 gene. Four types of IncF plasmids were
identified in multiple isolates from more than two hospitals: (i)
the F31:A-;B6 plasmid in six isolates of two different STs
(ST405 and ST648) from two hospitals; (ii) the F2:A-:B- plasmid
in four isolates of three different STs (ST38, ST68 and ST69)
from two hospitals; (iii) the F-:A1:B- plasmid in three isolates of
three different STs (ST14, ST68 and ST70) from three hospitals;
and (iv) the F-:A-:B20 plasmid in two isolates of two different
STs (ST131 and ST1177) from two hospitals. Clinical isolates of
ST38, ST69, ST131, ST354 and ST405 were recovered in multiple
hospitals, but different types of IncF plasmids were found in iso-
lates of the same ST from different hospitals. For example, iso-
lates of ST354 were recovered in three hospitals, with the
blaCTX-M-14 gene located on three different plasmids (F44:A1:B1,
F29:A1;B- and F44:A-:B-).
The spread of blaCTX-M-14 in E. coli in Spain is reported to be
conferred by IncK plasmids,9,17 while in Korea and France,
blaCTX-M-14 is mostly carried on IncF plasmids.
7 During the last
40 years, the blaTEM-1 gene carried by IncF plasmids, which are
well adapted to E. coli, has successfully diffused into E. coli
strains around the world. In fact, these plasmids, which were
responsible for the blaTEM-1 outbreak in the late 1980s, are now
the vehicle for the successful dissemination of the blaCTX-M-14
gene.18 The results of our study, which showed that the
blaTEM-1 gene was present in the same IncF plasmids carrying
the blaCTX-M-14 gene in many isolates, support this model.
In this study, E. coli isolates of diverse STs carried the
blaCTX-M-14 gene, and the gene was located on IncF plasmids of
diverse replicon sequence types. Four types of plasmids were
identified in more than two isolates from different hospitals. Iso-
lates of the same ST from different hospitals harboured different
types of IncF plasmids carrying the blaCTX-M-14 gene. These
results suggest that horizontal transfer of some IncF plasmids,
rather than clonal expansion, may play a role in dissemination
of the blaCTX-M-14 gene in E. coli isolates. Furthermore, our
results show the usefulness of plasmid replicon typing in study-
ing the epidemiology of ESBL-producing isolates.
The chromosomal location of genes encoding CTX-M ESBLs in
Enterobacteriaceae other than Proteus mirabilis has rarely been
described, although Coque et al.19 recently reported eight
E. coli isolates carrying the chromosome-borne blaCTX-M-15 gene.
Of note, the blaCTX-M-14 gene was located in the chromosome
in 13 E. coli clinical isolates in this study. The blaCTX-M-14 gene
in the chromosome was surrounded by genetic environments
similar to those on plasmids, supporting the hypothesis that
the blaCTX-M-14 gene integrated into chromosome via transposa-
ble elements such as ISEcp1-like elements in E. coli strains.20
In conclusion, the present data suggest that dissemination of
the blaCTX-M-14 gene in E. coli isolates in Korea is due to horizontal
transfer of IncF plasmids rather than clonal expansion. Interest-
ingly, the blaCTX-M-14 gene was chromosomally located in many
E. coli isolates. The clinical significance of this phenomenon
needs to be elucidated.
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